Radisens Diagnostics

Radisens Diagnostics was recently selected as one of six companies to partake in the recently announced National Healthcare Innovation Hub pilot launched to support the development and implementation of new healthcare innovations.

This involves the HSE and hi-tech companies collaborating to provide an effective route for new healthcare innovations from industry to access the HSE.

Based in the Rubicon Centre, Cork, Radisens is breaking new ground in the decentralisation of routine blood testing from laboratories into GP surgeries, outpatient clinics, hospital bedsides, and other point-of-care settings.

The diagnostic device returns laboratory-grade results in minutes during a GP visit.

With Ireland spending up to €1.45bn annually on managing chronic diabetes, the clinical reference site will pilot the design and efficient integration of the technology, which promises huge savings for chronic disease management.

“Decentralising the long-term disease management to point of care, leads to significantly improved patient care, and productivity gains and efficiencies within the healthcare system,” said Jerry O’Brien.

Earlier this year, Radisens won a €1m contract by the European Space Agency to develop a blood testing device for use on board the International Space Station.

Words of wisdom: ‘Mentors have a critical role in nurturing start-up businesses’.